[Medical-economic analysis: a necessary complement to "evidence based medicine"]

Area of Science:

• Health Economics
• Medical Technology Assessment

Background:

• Modern medicine faces increasing demands for efficiency, appropriateness, and cost-effectiveness.
• Evidence-based medicine (EBM) prioritizes healthcare benefits but often overlooks resource utilization.
• Economic analyses are essential to complement EBM by assessing the resources required for achieving health benefits.

Purpose of the Study:

• To present various cost types, analytical perspectives, and methods for assessing benefits and uncertainty in economic evaluations.
• To illustrate the application of these economic principles with examples from primary care and advanced medical technology.
• To emphasize the necessity of integrating both clinical efficacy and economic data for comprehensive medical procedure assessment.

Main Methods:

• Review of cost types, analytical perspectives, and benefit/uncertainty assessment techniques.
• Application of economic evaluation principles to two distinct medical scenarios: primary care and advanced technology.
• Comparative analysis of cost-benefit ratios based on patient populations and technological advancement stages.

Main Results:

• Cost-benefit ratios are highly sensitive to patient characteristics and the maturity of medical technologies.
• Economic analyses reveal the resource implications of diagnostic and therapeutic procedures, complementing EBM findings.
• The integration of clinical and economic data provides a more complete picture of a procedure's value.

Conclusions:

• Both evidence-based medicine and economic analyses are indispensable for a thorough evaluation of medical procedures.
• Understanding cost-benefit dynamics across different patient groups and technological stages is critical for healthcare decision-making.
• A holistic approach, considering both clinical benefits and economic impact, ensures efficient and appropriate healthcare resource allocation.